
Thermo Fisher's Q2 beats expectations; price target raised to $630 with 10% upside potential.
Thermo Fisher Scientific reported strong Q2 results with adjusted EPS of $6.03 and nearly $12 billion in sales, surpassing analyst estimates. The company saw broad growth across all segments, including Life Sciences Solutions, Analytical Instruments,...

